nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—Bullous eruption—Furosemide—dilated cardiomyopathy	0.0181	0.0181	CcSEcCtD
Cevimeline—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.0172	0.0172	CcSEcCtD
Cevimeline—Breast pain—Spironolactone—dilated cardiomyopathy	0.0151	0.0151	CcSEcCtD
Cevimeline—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.015	0.015	CcSEcCtD
Cevimeline—Pyelonephritis—Lisinopril—dilated cardiomyopathy	0.0141	0.0141	CcSEcCtD
Cevimeline—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0135	0.0135	CcSEcCtD
Cevimeline—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0129	0.0129	CcSEcCtD
Cevimeline—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.0124	0.0124	CcSEcCtD
Cevimeline—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0121	0.0121	CcSEcCtD
Cevimeline—Leg pain—Lisinopril—dilated cardiomyopathy	0.0116	0.0116	CcSEcCtD
Cevimeline—Bursitis—Lisinopril—dilated cardiomyopathy	0.0111	0.0111	CcSEcCtD
Cevimeline—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.0109	0.0109	CcSEcCtD
Cevimeline—Renal pain—Lisinopril—dilated cardiomyopathy	0.0102	0.0102	CcSEcCtD
Cevimeline—Apathy—Furosemide—dilated cardiomyopathy	0.01	0.01	CcSEcCtD
Cevimeline—Flat affect—Furosemide—dilated cardiomyopathy	0.00992	0.00992	CcSEcCtD
Cevimeline—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.0089	0.0089	CcSEcCtD
Cevimeline—Glycosuria—Furosemide—dilated cardiomyopathy	0.00883	0.00883	CcSEcCtD
Cevimeline—Gastritis—Spironolactone—dilated cardiomyopathy	0.00845	0.00845	CcSEcCtD
Cevimeline—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00817	0.00817	CcSEcCtD
Cevimeline—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00771	0.00771	CcSEcCtD
Cevimeline—Gout—Furosemide—dilated cardiomyopathy	0.00766	0.00766	CcSEcCtD
Cevimeline—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0076	0.0076	CcSEcCtD
Cevimeline—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00752	0.00752	CcSEcCtD
Cevimeline—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00751	0.00751	CcSEcCtD
Cevimeline—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00745	0.00745	CcSEcCtD
Cevimeline—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00745	0.00745	CcSEcCtD
Cevimeline—Vasculitis—Furosemide—dilated cardiomyopathy	0.00733	0.00733	CcSEcCtD
Cevimeline—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00728	0.00728	CcSEcCtD
Cevimeline—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00725	0.00725	CcSEcCtD
Cevimeline—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00713	0.00713	CcSEcCtD
Cevimeline—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00701	0.00701	CcSEcCtD
Cevimeline—Otitis media—Lisinopril—dilated cardiomyopathy	0.00689	0.00689	CcSEcCtD
Cevimeline—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00686	0.00686	CcSEcCtD
Cevimeline—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00657	0.00657	CcSEcCtD
Cevimeline—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00647	0.00647	CcSEcCtD
Cevimeline—Urine output increased—Furosemide—dilated cardiomyopathy	0.00647	0.00647	CcSEcCtD
Cevimeline—Bladder pain—Furosemide—dilated cardiomyopathy	0.00647	0.00647	CcSEcCtD
Cevimeline—Mental disability—Furosemide—dilated cardiomyopathy	0.00621	0.00621	CcSEcCtD
Cevimeline—Breast pain—Lisinopril—dilated cardiomyopathy	0.00615	0.00615	CcSEcCtD
Cevimeline—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.006	0.006	CcSEcCtD
Cevimeline—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00597	0.00597	CcSEcCtD
Cevimeline—Viral infection—Lisinopril—dilated cardiomyopathy	0.00594	0.00594	CcSEcCtD
Cevimeline—Polyuria—Furosemide—dilated cardiomyopathy	0.00591	0.00591	CcSEcCtD
Cevimeline—Arthropathy—Lisinopril—dilated cardiomyopathy	0.0059	0.0059	CcSEcCtD
Cevimeline—Alopecia—Spironolactone—dilated cardiomyopathy	0.00583	0.00583	CcSEcCtD
Cevimeline—Oliguria—Lisinopril—dilated cardiomyopathy	0.00582	0.00582	CcSEcCtD
Cevimeline—Deafness—Furosemide—dilated cardiomyopathy	0.0058	0.0058	CcSEcCtD
Cevimeline—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0058	0.0058	CcSEcCtD
Cevimeline—Gout—Lisinopril—dilated cardiomyopathy	0.00575	0.00575	CcSEcCtD
Cevimeline—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00571	0.00571	CcSEcCtD
Cevimeline—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00553	0.00553	CcSEcCtD
Cevimeline—Vasculitis—Lisinopril—dilated cardiomyopathy	0.0055	0.0055	CcSEcCtD
Cevimeline—Thirst—Furosemide—dilated cardiomyopathy	0.00546	0.00546	CcSEcCtD
Cevimeline—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00543	0.00543	CcSEcCtD
Cevimeline—Purpura—Furosemide—dilated cardiomyopathy	0.00539	0.00539	CcSEcCtD
Cevimeline—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00537	0.00537	CcSEcCtD
Cevimeline—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00533	0.00533	CcSEcCtD
Cevimeline—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00527	0.00527	CcSEcCtD
Cevimeline—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00524	0.00524	CcSEcCtD
Cevimeline—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00521	0.00521	CcSEcCtD
Cevimeline—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00521	0.00521	CcSEcCtD
Cevimeline—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00521	0.00521	CcSEcCtD
Cevimeline—Malaise—Spironolactone—dilated cardiomyopathy	0.00518	0.00518	CcSEcCtD
Cevimeline—Cystitis—Lisinopril—dilated cardiomyopathy	0.00518	0.00518	CcSEcCtD
Cevimeline—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00515	0.00515	CcSEcCtD
Cevimeline—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00507	0.00507	CcSEcCtD
Cevimeline—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00504	0.00504	CcSEcCtD
Cevimeline—Urinary retention—Furosemide—dilated cardiomyopathy	0.00494	0.00494	CcSEcCtD
Cevimeline—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00485	0.00485	CcSEcCtD
Cevimeline—Discomfort—Spironolactone—dilated cardiomyopathy	0.00484	0.00484	CcSEcCtD
Cevimeline—Dehydration—Furosemide—dilated cardiomyopathy	0.00483	0.00483	CcSEcCtD
Cevimeline—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00474	0.00474	CcSEcCtD
Cevimeline—Confusional state—Spironolactone—dilated cardiomyopathy	0.00473	0.00473	CcSEcCtD
Cevimeline—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00473	0.00473	CcSEcCtD
Cevimeline—Hypertonia—Lisinopril—dilated cardiomyopathy	0.0047	0.0047	CcSEcCtD
Cevimeline—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00459	0.00459	CcSEcCtD
Cevimeline—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00458	0.00458	CcSEcCtD
Cevimeline—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00452	0.00452	CcSEcCtD
Cevimeline—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00448	0.00448	CcSEcCtD
Cevimeline—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00444	0.00444	CcSEcCtD
Cevimeline—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.0044	0.0044	CcSEcCtD
Cevimeline—Eczema—Lisinopril—dilated cardiomyopathy	0.00434	0.00434	CcSEcCtD
Cevimeline—Injury—Lisinopril—dilated cardiomyopathy	0.00424	0.00424	CcSEcCtD
Cevimeline—Somnolence—Spironolactone—dilated cardiomyopathy	0.00417	0.00417	CcSEcCtD
Cevimeline—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00415	0.00415	CcSEcCtD
Cevimeline—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.0041	0.0041	CcSEcCtD
Cevimeline—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00409	0.00409	CcSEcCtD
Cevimeline—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00405	0.00405	CcSEcCtD
Cevimeline—Arthritis—Lisinopril—dilated cardiomyopathy	0.00401	0.00401	CcSEcCtD
Cevimeline—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00399	0.00399	CcSEcCtD
Cevimeline—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00391	0.00391	CcSEcCtD
Cevimeline—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Cevimeline—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Cevimeline—Diplopia—Lisinopril—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Cevimeline—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00387	0.00387	CcSEcCtD
Cevimeline—Face oedema—Lisinopril—dilated cardiomyopathy	0.00376	0.00376	CcSEcCtD
Cevimeline—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00373	0.00373	CcSEcCtD
Cevimeline—Urticaria—Spironolactone—dilated cardiomyopathy	0.00373	0.00373	CcSEcCtD
Cevimeline—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00371	0.00371	CcSEcCtD
Cevimeline—Dehydration—Lisinopril—dilated cardiomyopathy	0.00362	0.00362	CcSEcCtD
Cevimeline—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00356	0.00356	CcSEcCtD
Cevimeline—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00352	0.00352	CcSEcCtD
Cevimeline—Visual impairment—Furosemide—dilated cardiomyopathy	0.00346	0.00346	CcSEcCtD
Cevimeline—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00346	0.00346	CcSEcCtD
Cevimeline—Gastritis—Lisinopril—dilated cardiomyopathy	0.00345	0.00345	CcSEcCtD
Cevimeline—Asthma—Lisinopril—dilated cardiomyopathy	0.00337	0.00337	CcSEcCtD
Cevimeline—Eye disorder—Furosemide—dilated cardiomyopathy	0.00336	0.00336	CcSEcCtD
Cevimeline—Tinnitus—Furosemide—dilated cardiomyopathy	0.00335	0.00335	CcSEcCtD
Cevimeline—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00333	0.00333	CcSEcCtD
Cevimeline—Pruritus—Spironolactone—dilated cardiomyopathy	0.00332	0.00332	CcSEcCtD
Cevimeline—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00331	0.00331	CcSEcCtD
Cevimeline—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00328	0.00328	CcSEcCtD
Cevimeline—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00328	0.00328	CcSEcCtD
Cevimeline—Angiopathy—Furosemide—dilated cardiomyopathy	0.00326	0.00326	CcSEcCtD
Cevimeline—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00324	0.00324	CcSEcCtD
Cevimeline—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00321	0.00321	CcSEcCtD
Cevimeline—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00321	0.00321	CcSEcCtD
Cevimeline—Dysuria—Lisinopril—dilated cardiomyopathy	0.00315	0.00315	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00313	0.00313	CcSEcCtD
Cevimeline—Malnutrition—Furosemide—dilated cardiomyopathy	0.00313	0.00313	CcSEcCtD
Cevimeline—Dizziness—Spironolactone—dilated cardiomyopathy	0.0031	0.0031	CcSEcCtD
Cevimeline—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.0031	0.0031	CcSEcCtD
Cevimeline—Flatulence—Furosemide—dilated cardiomyopathy	0.00308	0.00308	CcSEcCtD
Cevimeline—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00307	0.00307	CcSEcCtD
Cevimeline—Weight increased—Lisinopril—dilated cardiomyopathy	0.00306	0.00306	CcSEcCtD
Cevimeline—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00306	0.00306	CcSEcCtD
Cevimeline—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00305	0.00305	CcSEcCtD
Cevimeline—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00304	0.00304	CcSEcCtD
Cevimeline—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00302	0.00302	CcSEcCtD
Cevimeline—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00301	0.00301	CcSEcCtD
Cevimeline—Depression—Lisinopril—dilated cardiomyopathy	0.00299	0.00299	CcSEcCtD
Cevimeline—Vomiting—Spironolactone—dilated cardiomyopathy	0.00298	0.00298	CcSEcCtD
Cevimeline—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00296	0.00296	CcSEcCtD
Cevimeline—Rash—Spironolactone—dilated cardiomyopathy	0.00296	0.00296	CcSEcCtD
Cevimeline—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00296	0.00296	CcSEcCtD
Cevimeline—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00294	0.00294	CcSEcCtD
Cevimeline—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00294	0.00294	CcSEcCtD
Cevimeline—Headache—Spironolactone—dilated cardiomyopathy	0.00294	0.00294	CcSEcCtD
Cevimeline—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00292	0.00292	CcSEcCtD
Cevimeline—Anaemia—Furosemide—dilated cardiomyopathy	0.00289	0.00289	CcSEcCtD
Cevimeline—Agitation—Furosemide—dilated cardiomyopathy	0.00287	0.00287	CcSEcCtD
Cevimeline—Haematuria—Lisinopril—dilated cardiomyopathy	0.00286	0.00286	CcSEcCtD
Cevimeline—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00283	0.00283	CcSEcCtD
Cevimeline—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00282	0.00282	CcSEcCtD
Cevimeline—Vertigo—Furosemide—dilated cardiomyopathy	0.00281	0.00281	CcSEcCtD
Cevimeline—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0028	0.0028	CcSEcCtD
Cevimeline—Leukopenia—Furosemide—dilated cardiomyopathy	0.0028	0.0028	CcSEcCtD
Cevimeline—Nausea—Spironolactone—dilated cardiomyopathy	0.00279	0.00279	CcSEcCtD
Cevimeline—Rhinitis—Lisinopril—dilated cardiomyopathy	0.0027	0.0027	CcSEcCtD
Cevimeline—Hallucination—Lisinopril—dilated cardiomyopathy	0.00268	0.00268	CcSEcCtD
Cevimeline—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00268	0.00268	CcSEcCtD
Cevimeline—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00266	0.00266	CcSEcCtD
Cevimeline—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00264	0.00264	CcSEcCtD
Cevimeline—Confusional state—Furosemide—dilated cardiomyopathy	0.00257	0.00257	CcSEcCtD
Cevimeline—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00251	0.00251	CcSEcCtD
Cevimeline—Shock—Furosemide—dilated cardiomyopathy	0.00251	0.00251	CcSEcCtD
Cevimeline—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.0025	0.0025	CcSEcCtD
Cevimeline—Flushing—Lisinopril—dilated cardiomyopathy	0.0025	0.0025	CcSEcCtD
Cevimeline—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.0025	0.0025	CcSEcCtD
Cevimeline—Skin disorder—Furosemide—dilated cardiomyopathy	0.00248	0.00248	CcSEcCtD
Cevimeline—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00247	0.00247	CcSEcCtD
Cevimeline—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00245	0.00245	CcSEcCtD
Cevimeline—Anorexia—Furosemide—dilated cardiomyopathy	0.00243	0.00243	CcSEcCtD
Cevimeline—Chills—Lisinopril—dilated cardiomyopathy	0.00242	0.00242	CcSEcCtD
Cevimeline—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00241	0.00241	CcSEcCtD
Cevimeline—Hypotension—Furosemide—dilated cardiomyopathy	0.00238	0.00238	CcSEcCtD
Cevimeline—Alopecia—Lisinopril—dilated cardiomyopathy	0.00238	0.00238	CcSEcCtD
Cevimeline—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00235	0.00235	CcSEcCtD
Cevimeline—Flatulence—Lisinopril—dilated cardiomyopathy	0.00231	0.00231	CcSEcCtD
Cevimeline—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.0023	0.0023	CcSEcCtD
Cevimeline—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00229	0.00229	CcSEcCtD
Cevimeline—Back pain—Lisinopril—dilated cardiomyopathy	0.00227	0.00227	CcSEcCtD
Cevimeline—Somnolence—Furosemide—dilated cardiomyopathy	0.00227	0.00227	CcSEcCtD
Cevimeline—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00226	0.00226	CcSEcCtD
Cevimeline—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00222	0.00222	CcSEcCtD
Cevimeline—Fatigue—Furosemide—dilated cardiomyopathy	0.0022	0.0022	CcSEcCtD
Cevimeline—Tremor—Lisinopril—dilated cardiomyopathy	0.0022	0.0022	CcSEcCtD
Cevimeline—Constipation—Furosemide—dilated cardiomyopathy	0.00218	0.00218	CcSEcCtD
Cevimeline—Pain—Furosemide—dilated cardiomyopathy	0.00218	0.00218	CcSEcCtD
Cevimeline—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00218	0.00218	CcSEcCtD
Cevimeline—Anaemia—Lisinopril—dilated cardiomyopathy	0.00217	0.00217	CcSEcCtD
Cevimeline—Malaise—Lisinopril—dilated cardiomyopathy	0.00212	0.00212	CcSEcCtD
Cevimeline—Vertigo—Lisinopril—dilated cardiomyopathy	0.00211	0.00211	CcSEcCtD
Cevimeline—Syncope—Lisinopril—dilated cardiomyopathy	0.0021	0.0021	CcSEcCtD
Cevimeline—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0021	0.0021	CcSEcCtD
Cevimeline—Leukopenia—Lisinopril—dilated cardiomyopathy	0.0021	0.0021	CcSEcCtD
Cevimeline—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00209	0.00209	CcSEcCtD
Cevimeline—Palpitations—Lisinopril—dilated cardiomyopathy	0.00207	0.00207	CcSEcCtD
Cevimeline—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00206	0.00206	CcSEcCtD
Cevimeline—Cough—Lisinopril—dilated cardiomyopathy	0.00205	0.00205	CcSEcCtD
Cevimeline—Urticaria—Furosemide—dilated cardiomyopathy	0.00203	0.00203	CcSEcCtD
Cevimeline—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00202	0.00202	CcSEcCtD
Cevimeline—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00202	0.00202	CcSEcCtD
Cevimeline—Chest pain—Lisinopril—dilated cardiomyopathy	0.002	0.002	CcSEcCtD
Cevimeline—Arthralgia—Lisinopril—dilated cardiomyopathy	0.002	0.002	CcSEcCtD
Cevimeline—Myalgia—Lisinopril—dilated cardiomyopathy	0.002	0.002	CcSEcCtD
Cevimeline—Anxiety—Lisinopril—dilated cardiomyopathy	0.00199	0.00199	CcSEcCtD
Cevimeline—Discomfort—Lisinopril—dilated cardiomyopathy	0.00197	0.00197	CcSEcCtD
Cevimeline—Confusional state—Lisinopril—dilated cardiomyopathy	0.00193	0.00193	CcSEcCtD
Cevimeline—Oedema—Lisinopril—dilated cardiomyopathy	0.00191	0.00191	CcSEcCtD
Cevimeline—Infection—Lisinopril—dilated cardiomyopathy	0.0019	0.0019	CcSEcCtD
Cevimeline—Shock—Lisinopril—dilated cardiomyopathy	0.00188	0.00188	CcSEcCtD
Cevimeline—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00188	0.00188	CcSEcCtD
Cevimeline—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00187	0.00187	CcSEcCtD
Cevimeline—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00187	0.00187	CcSEcCtD
Cevimeline—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00186	0.00186	CcSEcCtD
Cevimeline—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00185	0.00185	CcSEcCtD
Cevimeline—Asthenia—Furosemide—dilated cardiomyopathy	0.00183	0.00183	CcSEcCtD
Cevimeline—Anorexia—Lisinopril—dilated cardiomyopathy	0.00183	0.00183	CcSEcCtD
Cevimeline—Pruritus—Furosemide—dilated cardiomyopathy	0.00181	0.00181	CcSEcCtD
Cevimeline—Hypotension—Lisinopril—dilated cardiomyopathy	0.00179	0.00179	CcSEcCtD
Cevimeline—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00175	0.00175	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00174	0.00174	CcSEcCtD
Cevimeline—Insomnia—Lisinopril—dilated cardiomyopathy	0.00173	0.00173	CcSEcCtD
Cevimeline—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00172	0.00172	CcSEcCtD
Cevimeline—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00171	0.00171	CcSEcCtD
Cevimeline—Somnolence—Lisinopril—dilated cardiomyopathy	0.0017	0.0017	CcSEcCtD
Cevimeline—Dizziness—Furosemide—dilated cardiomyopathy	0.00169	0.00169	CcSEcCtD
Cevimeline—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00169	0.00169	CcSEcCtD
Cevimeline—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00166	0.00166	CcSEcCtD
Cevimeline—Fatigue—Lisinopril—dilated cardiomyopathy	0.00165	0.00165	CcSEcCtD
Cevimeline—Pain—Lisinopril—dilated cardiomyopathy	0.00164	0.00164	CcSEcCtD
Cevimeline—Constipation—Lisinopril—dilated cardiomyopathy	0.00164	0.00164	CcSEcCtD
Cevimeline—Vomiting—Furosemide—dilated cardiomyopathy	0.00162	0.00162	CcSEcCtD
Cevimeline—Rash—Furosemide—dilated cardiomyopathy	0.00161	0.00161	CcSEcCtD
Cevimeline—Dermatitis—Furosemide—dilated cardiomyopathy	0.00161	0.00161	CcSEcCtD
Cevimeline—Headache—Furosemide—dilated cardiomyopathy	0.0016	0.0016	CcSEcCtD
Cevimeline—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00158	0.00158	CcSEcCtD
Cevimeline—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00157	0.00157	CcSEcCtD
Cevimeline—Urticaria—Lisinopril—dilated cardiomyopathy	0.00152	0.00152	CcSEcCtD
Cevimeline—Nausea—Furosemide—dilated cardiomyopathy	0.00152	0.00152	CcSEcCtD
Cevimeline—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00151	0.00151	CcSEcCtD
Cevimeline—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00151	0.00151	CcSEcCtD
Cevimeline—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00141	0.00141	CcSEcCtD
Cevimeline—Asthenia—Lisinopril—dilated cardiomyopathy	0.00137	0.00137	CcSEcCtD
Cevimeline—Pruritus—Lisinopril—dilated cardiomyopathy	0.00135	0.00135	CcSEcCtD
Cevimeline—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00131	0.00131	CcSEcCtD
Cevimeline—Dizziness—Lisinopril—dilated cardiomyopathy	0.00127	0.00127	CcSEcCtD
Cevimeline—Vomiting—Lisinopril—dilated cardiomyopathy	0.00122	0.00122	CcSEcCtD
Cevimeline—Rash—Lisinopril—dilated cardiomyopathy	0.00121	0.00121	CcSEcCtD
Cevimeline—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00121	0.00121	CcSEcCtD
Cevimeline—Headache—Lisinopril—dilated cardiomyopathy	0.0012	0.0012	CcSEcCtD
Cevimeline—Nausea—Lisinopril—dilated cardiomyopathy	0.00114	0.00114	CcSEcCtD
